Abstract
Objective To investigate the efficacy of balloon dilatation combined with stent implantation
in the treatment of iliac vein compression syndrome (IVCS).
Methods This research was a retrospective study that enrolled 127 IVCS patients for clinical
data. The patients were divided into percutaneous transluminal angioplasty (PTA) group
(n = 63) and stent implantation group (n = 64). The PTA group was treated with iliac vein balloon dilatation, and the stent
implantation group was treated with combined stent implantation based on the PTA group.
In both the groups, the quality of life was assessed using Chronic Venous Insufficiency
Quality of Life Questionnaire (CIVIQ); complications occurring during the perioperative
period and at postoperative follow-up were recorded; the vascular patency rate was
calculated, and patient's condition was evaluated using the Villalta scale.
Results The stent implantation group exhibited lower postoperative CIVIQ scores than the
PTA group, and the stent implantation group (4.60%) had lower complication rate than
the PTA group (19.05%). At 2 years of follow-up, the stent implantation group (92.19%)
had higher vascular patency rate than the PTA group (79.37%). Villalta scores were
lower in the stent implantation group than in the PTA group at 6, 12, and 24 months
postoperatively.
Conclusion Iliac vein balloon dilatation combined with stent implantation for the treatment
of IVCS can improve vessel patency rates, alleviate patients' clinical symptoms, and
enhance their quality of life.
Keywords
iliac vein compression syndrome - balloon dilatation - stent implantation - endovascular
therapy - venous diseases - prognosis
